1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2021 Report). Available at: https://goldcopd.org/wpcontent/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf
2. Pavlenko V.I., Kolosov V.P., Naryshkina S.V. [Features of the comorbid course, prognosis and treatment of chronic obstructive pulmonary disease and coronary heart disease]. Blagoveshchensk; 2014 (in Russian). ISBN: 978-5-905864-07-0
3. Bakina A.A., Pavlenko V.I. [Chronic kidney disease as a manifestation of comorbidity in patients with chronic obstructive pulmonary disease]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2018; (69):115−122 (in Russian). https://doi.org/10.12737/article_5b985be86b47a1.51078145
4. Baranova I.A., Suleymanova A.K. [Osteoporosis and low-energy fractures in pulmonological patients: focus on chronic obstructive pulmonary disease]. Effektivnaya farmakoterapiya 2020; 16(19):52‒57 (in Russian). https://doi.org/10.33978/2307-3586-2020-16-19-52-57
5. Tanchenko O.A., Naryshkina S.V. [Obesity, metabolic disorders and hypertension in patients with chronic obstructive pulmonary disease: modern concepts of comorbidity (review)]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2016; (59):109‒118 (in Russian). https://cfpd.elpub.ru/jour/article/view/910